Nuclear and mitochondrial DNA oxidation in Alzheimer's disease

References

• Ittner LM, Gotz J. Amyloid-beta and tau–a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 2011;12:65–72.
   PubMed Web of Science ®Google Scholar
• Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010;362:329–344.
   PubMed Web of Science ®Google Scholar
• Santos RX, Moreira PI. mTOR is a potential therapeutic target for Alzhiemer's disease. In: Sun M–K, editor. Cognitive Sciences. Hauppauge, NY: Nova Science Publishers, Inc.; 2012. in press.
   Google Scholar
• Eisenstein M. Genetics: finding risk factors. Nature 2011; 475:S20–S22.
   PubMedGoogle Scholar
• Swerdlow RH, Burns JM, Khan SM. The Alzheimer's disease mitochondrial cascade hypothesis. J Alzheimers Dis 2010;20(Suppl 2):S265–279.
   PubMedGoogle Scholar
• Santos RX, Correia SC, Wang X, Perry G, Smith MA, Moreira PI, Zhu X. Alzheimer's disease: diverse aspects of mitochondrial malfunctioning. Int J Clin Exp Pathol 2010;3:570–581.
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Poon HF, St Clair D, Keller JN, Pierce WM, Klein JB, Markesbery WR. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis 2006;22:223–232.
   PubMed Web of Science ®Google Scholar
• Ding Q, Markesbery WR, Chen Q, Li F, Keller JN. Ribosome dysfunction is an early event in Alzheimer's disease. J Neurosci 2005;25:9171–9175.
   PubMed Web of Science ®Google Scholar
• Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfield DA, Markesbery WR. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 2005;64:1152–1156.
   PubMed Web of Science ®Google Scholar
• Markesbery WR, Kryscio RJ, Lovell MA, Morrow JD. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol 2005;58:730–735.
   PubMed Web of Science ®Google Scholar
• Wang J, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J Neurochem 2006;96:825–832.
   PubMed Web of Science ®Google Scholar
• Migliore L, Fontana I, Trippi F, Colognato R, Coppede F, Tognoni G, Nucciarone B, Siciliano G. Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging 2005;26:567–573.
   PubMed Web of Science ®Google Scholar
• Baldeiras I, Santana I, Proenca MT, Garrucho MH, Pascoal R, Rodrigues A, Duro D, Oliveira CR. Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment. J Alzheimers Dis 2010;21:1165–1177.
   PubMed Web of Science ®Google Scholar
• Lovell MA, Soman S, Bradley MA. Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain. Mech Ageing Dev 2011;132:443–448.
   PubMed Web of Science ®Google Scholar
• Gallagher JJ, Finnegan ME, Grehan B, Dobson J, Collingwood JF, Lynch MA. Modest amyloid deposition is associated with iron dysregulation, microglial activation, and oxidative stress. J Alzheimers Dis 2011; doi: 10.3233/JAD-2011-110614.
   Google Scholar
• Sims-Robinson C, Kim B, Rosko A, Feldman EL. How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol 2010;6:551–559.
   PubMed Web of Science ®Google Scholar
• Moreira PI, Duarte AI, Santos MS, Rego AC, Oliveira CR. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease. J Alzheimers Dis 2009;16:741–761.
   PubMed Web of Science ®Google Scholar
• Simm A, Brömme H-J. Reactive oxygen species (ROS) and aging: do we need them — can we measure them — should we block them? Signal Transd 2005;5:115–125.
   Google Scholar
• Terman A, Kurz T, Navratil M, Arriaga EA, Brunk UT. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid Redox Signal 2010;12:503–535.
   PubMed Web of Science ®Google Scholar
• Sayre LM, Perry G, Smith MA. Oxidative stress and neurotoxicity. Chem Res Toxicol 2008;21:172–188.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Cross CE. Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect 1994;102(Suppl 10):5–12.
   PubMedGoogle Scholar
• Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44–84.
   PubMed Web of Science ®Google Scholar
• Moreira PI, Nunomura A, Nakamura M, Takeda A, Shenk JC, Aliev G, Smith MA, Perry G. Nucleic acid oxidation in Alzheimer disease. Free Radic Biol Med 2008;44: 1493–1505.
   PubMedGoogle Scholar
• Mao P, Reddy PH. Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics. Biochim Biophys Acta 2011;1812:1359–1370.
   PubMed Web of Science ®Google Scholar
• Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res 2007;35:7497–7504.
   PubMed Web of Science ®Google Scholar
• Zawia NH, Lahiri DK, Cardozo-Pelaez F. Epigenetics, oxidative stress, and Alzheimer disease. Free Radic Biol Med 2009;46:1241–1249.
   PubMed Web of Science ®Google Scholar
• Scheffler IE. Mitochondria. Hoboken, NJ: John Wiley & Sons, Inc.; 2008.
   Google Scholar
• Nelson DL, Cox MM. Lehninger Principles of Biochemistry. New York: W.H. Freeman; 2004.
   Google Scholar
• Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979;59:527–605.
   PubMed Web of Science ®Google Scholar
• Moreira PI, Zhu X, Wang X, Lee HG, Nunomura A, Petersen RB, Perry G, Smith MA. Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta 2010;1802: 212–220.
   PubMed Web of Science ®Google Scholar
• Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009;417:1–13.
   PubMed Web of Science ®Google Scholar
• Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003;552:335–344.
   PubMed Web of Science ®Google Scholar
• Han D, Antunes F, Canali R, Rettori D, Cadenas E. Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol. J Biol Chem 2003;278:5557–5563.
   PubMed Web of Science ®Google Scholar
• Muller FL, Liu Y, Van Remmen H. Complex III releases superoxide to both sides of the inner mitochondrial membrane. J Biol Chem 2004;279:49064–49073.
   PubMed Web of Science ®Google Scholar
• Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005;39:359–407.
   PubMed Web of Science ®Google Scholar
• Green K, Brand MD, Murphy MP. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 2004;53(Suppl 1):S110–S118.
   PubMedGoogle Scholar
• Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci 2010;35:505–513.
   PubMed Web of Science ®Google Scholar
• Ribe EM, Serrano-Saiz E, Akpan N, Troy CM. Mechanisms of neuronal death in disease: defining the models and the players. Biochem J 2008;415:165–182.
   PubMed Web of Science ®Google Scholar
• Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, . Autophagocytosis of mitochondria is prominent in Alzheimer disease. J Neuropathol Exp Neurol 2007;66:525–532.
   PubMed Web of Science ®Google Scholar
• Fattoretti P, Balietti M, Casoli T, Giorgetti B, Di Stefano G, Bertoni-Freddari C, Lattanzio F, Sensi SL. Decreased numeric density of succinic dehydrogenase-positive mitochondria in CA1 pyramidal neurons of 3xTg-AD mice. Rejuvenation Res 2010;13:144–147.
   PubMedGoogle Scholar
• Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, . Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging 2009;30:1574–1586.
   PubMed Web of Science ®Google Scholar
• Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Nat Acad Sci USA 2009;106:14670–14675.
   PubMed Web of Science ®Google Scholar
• Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006;443: 787–795.
   PubMed Web of Science ®Google Scholar
• Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, . Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001;60:759–767.
   PubMed Web of Science ®Google Scholar
• Reddy PH, Beal MF. Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Brain Res Rev 2005;49:618–632.
   PubMedGoogle Scholar
• Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G. Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. Biochim Biophys Acta 2010;1802:2–10.
   PubMed Web of Science ®Google Scholar
• Maurer I, Zierz S, Moller HJ. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 2000;21:455–462.
   PubMed Web of Science ®Google Scholar
• Russell RL, Siedlak SL, Raina AK, Bautista JM, Smith MA, Perry G. Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. Arch Biochem Biophys 1999;370:236–239.
   PubMed Web of Science ®Google Scholar
• Parker WD Jr. Cytochrome oxidase deficiency in Alzheimer's disease. Ann NY Acad Sci 1991;640:59–64.
   PubMedGoogle Scholar
• Takuma K, Fang F, Zhang W, Yan S, Fukuzaki E, Du H, . RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction. Proc Natl Acad Sci USA 2009;106:20021–20026.
   PubMed Web of Science ®Google Scholar
• Humpel C, Marksteiner J. Cerebrovascular damage as a cause for Alzheimer's disease. Curr Neurovasc Res 2005;2: 341–347.
   PubMed Web of Science ®Google Scholar
• Atamna H, Frey WH2nd. A role for heme in Alzheimer's disease: heme binds amyloid beta and has altered metabolism. Proc Natl Acad Sci USA 2004;101:11153–11158.
   PubMed Web of Science ®Google Scholar
• Atamna H. Heme binding to Amyloid-beta peptide: mechanistic role in Alzheimer's disease. J Alzheimers Dis 2006;10: 255–266.
   PubMedGoogle Scholar
• Takuma K, Yao J, Huang J, Xu H, Chen X, Luddy J, . ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. FASEB J 2005;19:597–598.
   PubMed Web of Science ®Google Scholar
• Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, . ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 2004;304:448–452.
   PubMed Web of Science ®Google Scholar
• Yang TT, Hsu CT, Kuo YM. Amyloid precursor protein, heat-shock proteins, and Bcl-2 form a complex in mitochondria and modulate mitochondria function and apoptosis in N2a cells. Mech Ageing Dev 2009;130:592–601.
   PubMedGoogle Scholar
• Wallace DC, Stugard C, Murdock D, Schurr T, Brown MD. Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations. Proc Natl Acad Sci USA 1997;94:14900–14905.
   PubMed Web of Science ®Google Scholar
• Coskun PE, Beal MF, Wallace DC. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci USA 2004;101:10726–10731.
   PubMed Web of Science ®Google Scholar
• Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, Zhu X. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci USA 2008;105:19318–19323.
   PubMed Web of Science ®Google Scholar
• Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 2009;29:9090–9103.
   PubMed Web of Science ®Google Scholar
• Manczak M, Calkins MJ, Reddy PH. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Hum Mol Genet 2011;20:2495–2509.
   PubMed Web of Science ®Google Scholar
• Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum Mol Genet 2011;20:4515–4529.
   PubMed Web of Science ®Google Scholar
• Sheng B, Wang X, Su B, Lee HG, Casadesus G, Perry G, Zhu X. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J Neurochem 2011; doi: 10.1111/j.1471–4159.2011.07581.x.
   PubMedGoogle Scholar
• Budimir A. Metal ions, Alzheimer's disease and chelation therapy. Acta Pharm 2011;61:1–14.
   PubMed Web of Science ®Google Scholar
• Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, . An iron-responsive element type II in the 5′-untranslated region of the Alzheimer's amyloid precursor protein transcript. J Biol Chem 2002;277:45518–45528.
   PubMed Web of Science ®Google Scholar
• Smith MA, Zhu X, Tabaton M, Liu G, McKeel DW Jr, Cohen ML, . Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimers Dis 2010;19:363–372.
   PubMed Web of Science ®Google Scholar
• Lavados M, Guillon M, Mujica MC, Rojo LE, Fuentes P, Maccioni RB. Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron. J Alzheimers Dis 2008;13:225–232.
   PubMed Web of Science ®Google Scholar
• Moreira PI, Santos MS, Oliveira CR, Shenk JC, Nunomura A, Smith MA, Zhu X, Perry G. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurol Disord Drug Targets 2008;7:3–10.
   PubMed Web of Science ®Google Scholar
• Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann N Y Acad Sci 2004;1012:153–163.
   PubMed Web of Science ®Google Scholar
• Liu B, Moloney A, Meehan S, Morris K, Thomas SE, Serpell LC, . Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J Biol Chem 2011;286:4248–4256.
   PubMed Web of Science ®Google Scholar
• Bolognin S, Messori L, Drago D, Gabbiani C, Cendron L, Zatta P. Aluminum, copper, iron and zinc differentially alter amyloid-Abeta(1-42) aggregation and toxicity. Int J Biochem Cell Biol 2011;43:877–885.
   PubMed Web of Science ®Google Scholar
• Chen WT, Liao YH, Yu HM, Cheng IH, Chen YR. Distinct effects of Zn2 +, Cu2 +, Fe3 +, and Al3 + on amyloid-beta stability, oligomerization, and aggregation: amyloid-beta destabilization promotes annular protofibril formation. J Biol Chem 2011;286:9646–9656.
   PubMed Web of Science ®Google Scholar
• Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011;283:65–87.
   PubMed Web of Science ®Google Scholar
• Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem 2000;74:270–279.
   PubMed Web of Science ®Google Scholar
• Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, . The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry (Mosc) 1999;38: 7609–7616.
   Google Scholar
• Finefrock AE, Bush AI, Doraiswamy PM. Current status of metals as therapeutic targets in Alzheimer's disease. J Am Geriatr Soc 2003;51:1143–1148.
   PubMed Web of Science ®Google Scholar
• Block ML. NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci 2008;9(Suppl 2):S8.
   PubMedGoogle Scholar
• Simonyi A, He Y, Sheng W, Sun AY, Wood WG, Weisman GA, Sun GY. Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease. Mol Neurobiol 2010;41:73–86.
   PubMed Web of Science ®Google Scholar
• Babior BM. NADPH oxidase. Curr Opin Immunol 2004;16:42–47.
   PubMed Web of Science ®Google Scholar
• Zhu X, Su B, Wang X, Smith MA, Perry G. Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci 2007;64: 2202–2210.
   PubMed Web of Science ®Google Scholar
• Sorce S, Krause KH. NOX enzymes in the central nervous system: from signaling to disease. Antioxid Redox Signal 2009;11:2481–2504.
   PubMed Web of Science ®Google Scholar
• Klegeris A, McGeer PL. Beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J Neurosci Res 1997;49:229–235.
   PubMed Web of Science ®Google Scholar
• Shelat PB, Chalimoniuk M, Wang JH, Strosznajder JB, Lee JC, Sun AY, Simonyi A, Sun GY. Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J Neurochem 2008;106:45–55.
   PubMed Web of Science ®Google Scholar
• Van Muiswinkel FL, Veerhuis R, Eikelenboom P. Amyloid beta protein primes cultured rat microglial cells for an enhanced phorbol 12-myristate 13-acetate-induced respiratory burst activity. J Neurochem 1996;66:2468–2476.
   PubMedGoogle Scholar
• Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, . Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383–421.
   PubMed Web of Science ®Google Scholar
• Bruce-Keller AJ, Gupta S, Parrino TE, Knight AG, Ebenezer PJ, Weidner AM, . NOX activity is increased in mild cognitive impairment. Antioxid Redox Signal 2010;12: 1371–1382.
   PubMed Web of Science ®Google Scholar
• Ansari MA, Scheff SW. NADPH-oxidase activation and cognition in Alzheimer disease progression. Free Radic Biol Med 2011;51:171–178.
   PubMed Web of Science ®Google Scholar
• Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 2004;5: 347–360.
   PubMed Web of Science ®Google Scholar
• Park L, Zhou P, Pitstick R, Capone C, Anrather J, Norris EH, . Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc Natl Acad Sci USA 2008;105: 1347–1352.
   PubMed Web of Science ®Google Scholar
• Park L, Anrather J, Zhou P, Frys K, Pitstick R, Younkin S, Carlson GA, Iadecola C. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J Neurosci 2005;25: 1769–1777.
   PubMed Web of Science ®Google Scholar
• Dumont M, Lin MT, Beal MF. Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease. J Alzheimers Dis 2010;20(Suppl 2):S633–S643.
   PubMedGoogle Scholar
• Li F, Calingasan NY, Yu F, Mauck WM, Toidze M, Almeida CG, . Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J Neurochem 2004; 89:1308–1312.
   PubMed Web of Science ®Google Scholar
• Melov S, Adlard PA, Morten K, Johnson F, Golden TR, Hinerfeld D, . Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS ONE 2007;2:e536.
   PubMed Web of Science ®Google Scholar
• Esposito L, Raber J, Kekonius L, Yan F, Yu GQ, Bien-Ly N, . Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J Neurosci 2006;26: 5167–5179.
   PubMed Web of Science ®Google Scholar
• Dumont M, Wille E, Stack C, Calingasan NY, Beal MF, Lin MT. Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J 2009;23:2459–2466.
   PubMed Web of Science ®Google Scholar
• Massaad CA, Washington TM, Pautler RG, Klann E. Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 2009;106:13576–13581.
   PubMed Web of Science ®Google Scholar
• Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA, Freedman ML. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 1998;150:40–44.
   PubMed Web of Science ®Google Scholar
• Straface E, Matarrese P, Gambardella L, Vona R, Sgadari A, Silveri MC, Malorni W. Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: a pilot study. FEBS Lett 2005;579:2759–2766.
   PubMed Web of Science ®Google Scholar
• Schuessel K, Schafer S, Bayer TA, Czech C, Pradier L, Muller-Spahn F, Muller WE, Eckert A. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice. Neurobiol Dis 2005;18:89–99.
   PubMed Web of Science ®Google Scholar
• Habib LK, Lee MT, Yang J. Inhibitors of catalase-amyloid interactions protect cells from beta-amyloid-induced oxidative stress and toxicity. J Biol Chem 2010;285: 38933–38943.
   PubMedGoogle Scholar
• Hyun DH, Hernandez JO, Mattson MP, de Cabo R. The plasma membrane redox system in aging. Ageing Res Rev 2006;5:209–220.
   PubMed Web of Science ®Google Scholar
• Hyun DH, Hunt ND, Emerson SS, Hernandez JO, Mattson MP, de Cabo R. Up-regulation of plasma membrane-associated redox activities in neuronal cells lacking functional mitochondria. J Neurochem 2007;100:1364–1374.
   PubMedGoogle Scholar
• Navas P, Villalba JM, de Cabo R. The importance of plasma membrane coenzyme Q in aging and stress responses. Mitochondrion 2007;7(Suppl):S34–40.
   PubMedGoogle Scholar
• Rodriguez-Aguilera JC, Lopez-Lluch G, Santos-Ocana C, Villalba JM, Gomez-Diaz C, Navas P. Plasma membrane redox system protects cells against oxidative stress. Redox Rep 2000;5:148–150.
   PubMed Web of Science ®Google Scholar
• Villalba JM, Navas P. Plasma membrane redox system in the control of stress-induced apoptosis. Antioxid Redox Signal 2000;2:213–230.
   PubMed Web of Science ®Google Scholar
• Hyun DH, Mughal MR, Yang H, Lee JH, Ko EJ, Hunt ND, de Cabo R, Mattson MP. The plasma membrane redox system is impaired by amyloid beta-peptide and in the hippocampus and cerebral cortex of 3xTgAD mice. Exp Neurol 2010;225:423–429.
   PubMed Web of Science ®Google Scholar
• Resende R, Moreira PI, Proenca T, Deshpande A, Busciglio J, Pereira C, Oliveira CR. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 2008;44:2051–2057.
   PubMed Web of Science ®Google Scholar
• Nishida Y, Ito S, Ohtsuki S, Yamamoto N, Takahashi T, Iwata N, . Depletion of vitamin E increases amyloid beta accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease. J Biol Chem 2009; 284:33400–33408.
   PubMed Web of Science ®Google Scholar
• Gu M, Owen AD, Toffa SE, Cooper JM, Dexter DT, Jenner P, Marsden CD, Schapira AH. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. J Neurol Sci 1998;158:24–29.
   PubMedGoogle Scholar
• Bermejo P, Martin-Aragon S, Benedi J, Susin C, Felici E, Gil P, Ribera JM, Villar AM. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from mild cognitive impairment. Free Radic Res 2008;42:162–170.
   PubMed Web of Science ®Google Scholar
• Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, . Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 2003;24:915–919.
   PubMed Web of Science ®Google Scholar
• Cardoso SM, Oliveira CR. Glutathione cycle impairment mediates A beta-induced cell toxicity. Free Radic Res 2003;37:241–250.
   PubMed Web of Science ®Google Scholar
• Svilar D, Goellner EM, Almeida KH, Sobol RW. Base excision repair and lesion-dependent subpathways for repair of oxidative DNA damage. Antioxid Redox Signal 2011;14: 2491–2507.
   PubMed Web of Science ®Google Scholar
• Pisoni RL, Acker TL, Lisowski KM, Lemons RM, Thoene JG. A cysteine-specific lysosomal transport system provides a major route for the delivery of thiol to human fibroblast lysosomes: possible role in supporting lysosomal proteolysis. J Cell Biol 1990;110:327–335.
   PubMed Web of Science ®Google Scholar
• Brun A, Brunk U. Histochemical indications for lysosomal localization of heavy metals in normal rat brain and liver. J Histochem Cytochem 1970;18:820–827.
   PubMed Web of Science ®Google Scholar
• Petrat F, de Groot H, Rauen U. Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells. Biochem J 2001;356:61–69.
   PubMedGoogle Scholar
• Schafer FQ, Buettner GR. Acidic pH amplifies iron-mediated lipid peroxidation in cells. Free Radic Biol Med 2000;28:1175–1181.
   PubMed Web of Science ®Google Scholar
• Tenopoulou M, Doulias PT, Barbouti A, Brunk U, Galaris D. Role of compartmentalized redox-active iron in hydrogen peroxide-induced DNA damage and apoptosis. Biochem J 2005;387:703–710.
   PubMed Web of Science ®Google Scholar
• Kurz T, Leake A, Von Zglinicki T, Brunk UT. Relocalized redox-active lysosomal iron is an important mediator of oxidative-stress-induced DNA damage. Biochem J 2004;378: 1039–1045.
   PubMed Web of Science ®Google Scholar
• Ditaranto K, Tekirian TL, Yang AJ. Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol Dis 2001;8:19–31.
   PubMed Web of Science ®Google Scholar
• Yang AJ, Chandswangbhuvana D, Margol L, Glabe CG. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. J Neurosci Res 1998;52:691–698.
   PubMed Web of Science ®Google Scholar
• Jeppesen DK, Bohr VA, Stevnsner T. DNA repair deficiency in neurodegeneration. Prog Neurobiol 2011;94: 166–200.
   PubMed Web of Science ®Google Scholar
• Dizdaroglu M, Kirkali G, Jaruga P. Formamidopyrimidines in DNA: mechanisms of formation, repair, and biological effects. Free Radic Biol Med 2008;45:1610–1621.
   PubMed Web of Science ®Google Scholar
• Kasai H, Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 1984;12:2137–2145.
   PubMed Web of Science ®Google Scholar
• Maki H. Origins of spontaneous mutations: specificity and directionality of base-substitution, frameshift, and sequence-substitution mutageneses. Annu Rev Genet 2002;36: 279–303.
   PubMed Web of Science ®Google Scholar
• O'Connor TR, Boiteux S, Laval J. Ring-opened 7-methylguanine residues in DNA are a block to in vitro DNA synthesis. Nucleic Acids Res 1988;16:5879–5894.
   PubMed Web of Science ®Google Scholar
• Malins DC, Hellstrom KE, Anderson KM, Johnson PM, Vinson MA. Antioxidant-induced changes in oxidized DNA. Proc Natl Acad Sci USA 2002;99:5937–5941.
   PubMedGoogle Scholar
• Neeley WL, Essigmann JM. Mechanisms of formation, genotoxicity, and mutation of guanine oxidation products. Chem Res Toxicol 2006;19:491–505.
   PubMed Web of Science ®Google Scholar
• Hailer MK, Slade PG, Martin BD, Rosenquist TA, Sugden KD. Recognition of the oxidized lesions spiroiminodihydantoin and guanidinohydantoin in DNA by the mammalian base excision repair glycosylases NEIL1 and NEIL2. DNA Repair (Amst) 2005;4:41–50.
   PubMedGoogle Scholar
• Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003;17:1195–1214.
   PubMed Web of Science ®Google Scholar
• Steenken S. Purine bases, nucleosides, and nucleotides: aqueous solution redox chemistry and transformation reactions of their radical cations and e- and OH adducts. Chem Rev 1989;89:503–520.
   Web of Science ®Google Scholar
• Dizdaroglu M. Base-excision repair of oxidative DNA damage by DNA glycosylases. Mutat Res 2005;591:45–59.
   PubMed Web of Science ®Google Scholar
• Weissman L, de Souza-Pinto NC, Stevnsner T, Bohr VA. DNA repair, mitochondria, and neurodegeneration. Neuroscience 2007;145:1318–1329.
   PubMed Web of Science ®Google Scholar
• Huffman JL, Sundheim O, Tainer JA. DNA base damage recognition and removal: new twists and grooves. Mutat Res 2005;577:55–76.
   PubMed Web of Science ®Google Scholar
• Stivers JT, Jiang YL. A mechanistic perspective on the chemistry of DNA repair glycosylases. Chem Rev 2003;103: 2729–2759.
   PubMed Web of Science ®Google Scholar
• Morland I, Rolseth V, Luna L, Rognes T, Bjoras M, Seeberg E. Human DNA glycosylases of the bacterial Fpg/MutM superfamily: an alternative pathway for the repair of 8-oxoguanine and other oxidation products in DNA. Nucleic Acids Res 2002;30:4926–4936.
   PubMed Web of Science ®Google Scholar
• Hazra TK, Izumi T, Boldogh I, Imhoff B, Kow YW, Jaruga P, Dizdaroglu M, Mitra S. Identification and characterization of a human DNA glycosylase for repair of modified bases in oxidatively damaged DNA. Proc Natl Acad Sci USA 2002;99:3523–3528.
   PubMed Web of Science ®Google Scholar
• Ide H, Kotera M. Human DNA glycosylases involved in the repair of oxidatively damaged DNA. Biol Pharm Bull 2004;27:480–485.
   PubMedGoogle Scholar
• Klungland A, Rosewell I, Hollenbach S, Larsen E, Daly G, Epe B, . Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc Natl Acad Sci USA 1999;96:13300–13305.
   PubMed Web of Science ®Google Scholar
• de Souza-Pinto NC, Eide L, Hogue BA, Thybo T, Stevnsner T, Seeberg E, Klungland A, Bohr VA. Repair of 8-oxodeoxyguanosine lesions in mitochondrial dna depends on the oxoguanine dna glycosylase (OGG1) gene and 8-oxoguanine accumulates in the mitochondrial dna of OGG1-defective mice. Cancer Res 2001;61:5378–5381.
   PubMed Web of Science ®Google Scholar
• Demple B, Sung JS. Molecular and biological roles of Ape1 protein in mammalian base excision repair. DNA Repair (Amst) 2005;4:1442–1449.
   PubMed Web of Science ®Google Scholar
• Wilson DM 3rd, Barsky D. The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA. Mutat Res 2001;485:283–307.
   PubMedGoogle Scholar
• Bohr VA. Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radic Biol Med 2002;32:804–812.
   PubMed Web of Science ®Google Scholar
• Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, . Sequence and organization of the human mitochondrial genome. Nature 1981;290:457–465.
   PubMed Web of Science ®Google Scholar
• Stowe DF, Camara AK. Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid Redox Signal 2009;11: 1373–1414.
   PubMed Web of Science ®Google Scholar
• Yakes FM, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 1997;94:514–519.
   PubMed Web of Science ®Google Scholar
• Nilsen H, Otterlei M, Haug T, Solum K, Nagelhus TA, Skorpen F, Krokan HE. Nuclear and mitochondrial uracil-DNA glycosylases are generated by alternative splicing and transcription from different positions in the UNG gene. Nucleic Acids Res 1997;25:750–755.
   PubMedGoogle Scholar
• Nishioka K, Ohtsubo T, Oda H, Fujiwara T, Kang D, Sugimachi K, Nakabeppu Y. Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs. Mol Biol Cell 1999;10:1637–1652.
   PubMed Web of Science ®Google Scholar
• Hu J, de Souza-Pinto NC, Haraguchi K, Hogue BA, Jaruga P, Greenberg MM, Dizdaroglu M, Bohr VA. Repair of formamidopyrimidines in DNA involves different glycosylases: role of the OGG1, NTH1, and NEIL1 enzymes. J Biol Chem 2005;280:40544–40551.
   PubMed Web of Science ®Google Scholar
• Fung H, Kow YW, Van Houten B, Taatjes DJ, Hatahet Z, Janssen YM, . Asbestos increases mammalian AP-endonuclease gene expression, protein levels, and enzyme activity in mesothelial cells. Cancer Res 1998;58:189–194.
   PubMed Web of Science ®Google Scholar
• Rivkees SA, Kelley MR. Expression of a multifunctional DNA repair enzyme gene, apurinic/apyrimidinic endonuclease (APE; Ref-1) in the suprachiasmatic, supraoptic and paraventricular nuclei. Brain Res 1994;666:137–142.
   PubMedGoogle Scholar
• Wilson TM, Rivkees SA, Deutsch WA, Kelley MR. Differential expression of the apurinic/apyrimidinic endonuclease (APE/ref-1) multifunctional DNA base excision repair gene during fetal development and in adult rat brain and testis. Mutat Res 1996;362:237–248.
   PubMed Web of Science ®Google Scholar
• Lakshmipathy U, Campbell C. Mitochondrial DNA ligase III function is independent of Xrcc1. Nucleic Acids Res 2000;28:3880–3886.
   PubMed Web of Science ®Google Scholar
• Lakshmipathy U, Campbell C. The human DNA ligase III gene encodes nuclear and mitochondrial proteins. Mol Cell Biol 1999;19:3869–3876.
   PubMed Web of Science ®Google Scholar
• Hansen AB, Griner NB, Anderson JP, Kujoth GC, Prolla TA, Loeb LA, Glick E. Mitochondrial DNA integrity is not dependent on DNA polymerase-beta activity. DNA Repair (Amst) 2006;5:71–79.
   PubMedGoogle Scholar
• Kaguni LS. DNA polymerase gamma, the mitochondrial replicase. Annu Rev Biochem 2004;73:293–320.
   PubMed Web of Science ®Google Scholar
• Intano GW, McMahan CA, McCarrey JR, Walter RB, McKenna AE, Matsumoto Y, . Base excision repair is limited by different proteins in male germ cell nuclear extracts prepared from young and old mice. Mol Cell Biol 2002;22: 2410–2418.
   PubMedGoogle Scholar
• Intano GW, Cho EJ, McMahan CA, Walter CA. Age-related base excision repair activity in mouse brain and liver nuclear extracts. J Gerontol A Biol Sci Med Sci 2003;58:205–211.
   PubMedGoogle Scholar
• Imam SZ, Karahalil B, Hogue BA, Souza-Pinto NC, Bohr VA. Mitochondrial and nuclear DNA-repair capacity of various brain regions in mouse is altered in an age-dependent manner. Neurobiol Aging 2006;27:1129–1136.
   PubMedGoogle Scholar
• Chen D, Cao G, Hastings T, Feng Y, Pei W, O'Horo C, Chen J. Age-dependent decline of DNA repair activity for oxidative lesions in rat brain mitochondria. J Neurochem 2002;81: 1273–1284.
   PubMedGoogle Scholar
• Szczesny B, Bhakat KK, Mitra S, Boldogh I. Age-dependent modulation of DNA repair enzymes by covalent modification and subcellular distribution. Mech Ageing Dev 2004;125:755–765.
   PubMed Web of Science ®Google Scholar
• Hegde ML, Hegde PM, Holthauzen LM, Hazra TK, Rao KS, Mitra S. Specific Inhibition of NEIL-initiated repair of oxidized base damage in human genome by copper and iron: potential etiological linkage to neurodegenerative diseases. J Biol Chem 2010;285:28812–28825.
   PubMedGoogle Scholar
• Cabelof DC, Raffoul JJ, Ge Y, Van Remmen H, Matherly LH, Heydari AR. Age-related loss of the DNA repair response following exposure to oxidative stress. J Gerontol A Biol Sci Med Sci 2006;61:427–434.
   PubMedGoogle Scholar
• Szczesny B, Hazra TK, Papaconstantinou J, Mitra S, Boldogh I. Age-dependent deficiency in import of mitochondrial DNA glycosylases required for repair of oxidatively damaged bases. Proc Natl Acad Sci USA 2003;100: 10670–10675.
   PubMed Web of Science ®Google Scholar
• Du Y, Wooten MC, Gearing M, Wooten MW. Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease. Free Radic Biol Med 2009;46:492–501.
   PubMed Web of Science ®Google Scholar
• Nakaso K, Yoshimoto Y, Nakano T, Takeshima T, Fukuhara Y, Yasui K, . Transcriptional activation of p62/A170/ZIP during the formation of the aggregates: possible mechanisms and the role in Lewy body formation in Parkinson's disease. Brain Res 2004;1012:42–51.
   PubMed Web of Science ®Google Scholar
• Ramesh Babu J, Lamar Seibenhener M, Peng J, Strom AL, Kemppainen R, Cox N, . Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J Neurochem 2008;106:107–120.
   PubMed Web of Science ®Google Scholar
• Weissman L, Jo DG, Sorensen MM, de Souza-Pinto NC, Markesbery WR, Mattson MP, Bohr VA. Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment. Nucleic Acids Res 2007;35:5545–5555.
   PubMedGoogle Scholar
• Dezor M, Dorszewska J, Florczak J, Kempisty B, Jaroszewska-Kolecka J, Rozycka A, . Expression of 8-oxoguanine DNA glycosylase 1 (OGG1) and the level of p53 and TNF-alphalpha proteins in peripheral lymphocytes of patients with Alzheimer's disease. Folia Neuropathol 2011;49: 123–131.
   PubMedGoogle Scholar
• Shao C, Xiong S, Li GM, Gu L, Mao G, Markesbery WR, Lovell MA. Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain. Free Radic Biol Med 2008;45:813–819.
   PubMed Web of Science ®Google Scholar
• Weissman L, de Souza-Pinto NC, Mattson MP, Bohr VA. DNA base excision repair activities in mouse models of Alzheimer's disease. Neurobiol Aging 2009;30:2080–2081.
   PubMedGoogle Scholar
• Gredilla R, Weissman L, Yang JL, Bohr VA, Stevnsner T. Mitochondrial base excision repair in mouse synaptosomes during normal aging and in a model of Alzheimer's disease. Neurobiol Aging 2010; doi:10.1016/j.neurobiolaging.2010. 1006.1019.
   Google Scholar
• Kadioglu E, Sardas S, Aslan S, Isik E, Esat Karakaya A. Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer's disease. Biomarkers 2004;9: 203–209.
   PubMed Web of Science ®Google Scholar
• Mecocci P, Polidori MC, Ingegni T, Cherubini A, Chionne F, Cecchetti R, Senin U. Oxidative damage to DNA in lymphocytes from AD patients. Neurology 1998;51: 1014–1017.
   PubMed Web of Science ®Google Scholar
• Morocz M, Kalman J, Juhasz A, Sinko I, McGlynn AP, Downes CS, Janka Z, Rasko I. Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer's disease. Neurobiol Aging 2002;23:47–53.
   PubMed Web of Science ®Google Scholar
• Lovell MA, Gabbita SP, Markesbery WR. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J Neurochem 1999;72: 771–776.
   PubMed Web of Science ®Google Scholar
• Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem 2005;93:953–962.
   PubMed Web of Science ®Google Scholar
• Fukui H, Moraes CT. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends Neurosci 2008;31: 251–256.
   PubMed Web of Science ®Google Scholar
• Petrozzi L, Ricci G, Giglioli NJ, Siciliano G, Mancuso M. Mitochondria and neurodegeneration. Biosci Rep 2007;27: 87–104.
   PubMed Web of Science ®Google Scholar